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Abstract
Genotyping methods are essential to understand the transmission dynamics of Acinetobacter baumannii. We examined the
representative genotypes of A. baumannii at different time periods in select locations in Ohio, using two rapid automated
typing methods: PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS), a form of multi-locus sequence
typing (MLST), and repetitive-sequence-based-PCR (rep-PCR). Our analysis included 122 isolates from 4 referral hospital
systems, in 2 urban areas of Ohio. These isolates were associated with outbreaks at 3 different time periods (1996, 2000 and
2005–2007). Type assignments of PCR/ESI-MS and rep-PCR were compared to each other and to worldwide (WW) clone
types. The discriminatory power of each method was determined using the Simpson’s index of diversity (DI). We observed
that PCR/ESI-MS sequence type (ST) 14, corresponding to WW clone 3, predominated in 1996, whereas ST 12 and 14 co-
existed in the intermediate period (2000) and ST 10 and 12, belonging to WW clone 2, predominated more recently in 2007.
The shift from WW clone 3 to WW clone 2 was accompanied by an increase in carbapenem resistance. The DI was
approximately 0.74 for PCR/ESI-MS, 0.88 for rep-PCR and 0.90 for the combination of both typing methods. We conclude
that combining rapid automated typing methods such as PCR/ESI-MS and rep-PCR serves to optimally characterize the
regional molecular epidemiology of A. baumannii. Our data also sheds light on the changing sequence types in an 11 year
period in Northeast Ohio.
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Introduction
Acinetobacter baumannii has emerged worldwide as a cause of
infection among seriously ill patients [1]. A. baumannii is a frequent
cause of outbreaks in hospitals and long term care facilities, where
this pathogen is associated with prolonged hospitalizations and
possibly increased mortality [2,3]. Also, military medical facilities
treating personnel serving in Iraq and Afghanistan have
experienced A. baumannii outbreaks [4,5,6]. The remarkable ability
of A. baumannii to display resistance to multiple classes of
antibiotics, including carbapenems, poses a serious therapeutic
challenge and likely contributes to its global success as a healthcare-
associated pathogen [1,7,8].
Genetic typing is an essential tool in understanding the
transmission dynamics and temporal evolution of A. baumannii.
For instance, typing of DNA digests using pulsed field gel
electrophoresis (PFGE) enhances the epidemiological investigation
of outbreaks by demonstrating highly related or indistinguishable
isolates, suggesting transmission from a common source or from
patient-to-patient [9,10]. Comparing PFGE typing of A. baumannii
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protocols [11]. In this regard, the combination of PFGE,
ribotyping, and amplified fragment length polymorphism (AFLP)
permitted the identification of important international clones of A.
baumannii from different hospitals in Europe [12,13,14]. These
strains, European clones 1–3, are also found globally and thus are
now termed worldwide (WW) clones [12]. Multi-locus sequence
typing (MLST), a method suitable for pathogens with wide
genomic, temporal and spatial variations, has permitted further
characterization of the population structure, genetic diversity and
distinctness of the WW clones of A. baumannii [15]. The cost and
time-consuming nature of MLST, although becoming more
accessible, limit its current applicability except in specialized
circumstances [16].
Rapid and automated typing methods are increasingly applied
to A. baumannii. PCR coupled with electrospray ionization mass
spectrometry (PCR/ESI-MS) analyzes the base-composition of
amplicons from six housekeeping genes, generating a unique
signature that corresponds to a sequence type (ST) in a database
[17,18]. These genes, however, differ from the seven housekeeping
genes amplified and sequenced to perform MLST. Consequently,
the STs generated by PCR/ESI-MS do not correspond to those of
MLST schemes. Automated PCR/ESI-MS has been used to
investigate A. baumannii from civilian and military treatment
facilities revealing sequence types corresponding to the WW clones
[3,6,17,19]. Automated repetitive-sequence-based-PCR (rep-PCR)
has also been employed to type A. baumannii. Using rep-PCR,
a unique profile of bands is generated by the resolution of
amplified DNA fragments in a gel matrix. Automated rep-PCR
has been applied to the analysis of local outbreaks and to illustrate
the global spread of carbapenem-resistant lineages of A. baumannii
[3,12].
Insights into the molecular epidemiology of A. baumannii gained
from rapid automated methods aid in surveillance, demonstrate
the temporal pattern of strain replacement, and may lead to
successful interventions to control this important pathogen. In this
study, we investigate temporal changes in the molecular
epidemiology of A. baumannii in two urban centers in Ohio, and
explore the discriminatory ability of two rapid automated
methods, PCR/ESI-MS and rep-PCR.
Methods
Ethics Statement
Expedited approval was obtained from the Institutional Review
Board at Louis Stokes Cleveland VA Medical Center, IRB #
09084-H04. The bacterial isolates analyzed in this study belong to
the microbiological collections of each hospital and were obtained
as part of routine clinical care in the past. Furthermore, all patient
identifiers had been previously removed and data were analyzed
anonymously. Therefore, the Institutional Review Board waived
the need to obtain written or verbal consent.
Bacterial Isolates
A total of 122 single-patient isolates of A. baumannii were studied.
The isolates were identified and antimicrobial susceptibility testing
was performed with VITEKH (bioMe ´rieux, Durham, NC) or
Microscan (Siemens Healthcare, Deerfield, IL), at their respective
hospitals of origin. These were four tertiary-care hospital systems
from two cities in Ohio, which experienced outbreaks of A.
baumannii at three different time periods: 1996, 2000 and 2005–
2007 (Figure 1). Hospital systems A, B, and D are located in the
Cleveland, Ohio regional area and hospital system C is located
approximately 140 miles south in Columbus, Ohio. The isolates
were obtained from microbiological cultures of various types of
specimens (e.g., blood, sputum, urine, wounds) and belonged to
different patient populations (i.e., ICU, non-ICU, adult, pediatric,
medical, surgical, trauma and burn patients).
PCR/ESI-MS
Overnight cultures were diluted 1:50 in Tris-EDTA buffer and
were boiled at 99uC for 15 minutes prior to use. PCR/ESI-MS
was performed using the Acinetobacter genotyping kit on the
T5000
TM Biosensor (Ibis Biosciences, Inc., Abbott Molecular,
Inc., Carlsbad, CA). The base composition analysis was completed
using the provided software. The software compared our
amplicons to previously obtained sequences stored in a database
in order to assign the sequence type (ST) of each strain, as
previously described and validated [17]. PCR/ESI-MS STs were
correlated with WW clones 1–3, according to previously published
studies [6,17,19].
Rep-PCR
Genomic DNA was extracted from bacterial isolates using the
UltraClean
TM Microbial DNA Isolation Kit (MoBio Laboratories,
Carlsbad, CA). PCR amplification was performed using the
DiversiLabH (bioMe ´rieux, Athens, GA) Acinetobacter fingerprinting
kit, according to the manufacturer’s instructions. Rep-PCR
products were separated by electrophoresis on microfluidic chips
and analyzed with the Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA). The resulting band patterns
were compared in order to generate a dendrogram using two
different statistical methods: Pearson correlation (PC) and the
modified Kullback–Leibler (KL). Both methods calculate similarity
using relative band intensity, however, PC is more ‘‘band
intensity’’ based and KL is more ‘‘band presence’’ driven. As
validated in previous studies, isolates having band patterns with
$95% similarity were considered genetically related strains
(genotypic clusters) [3,12]. In a further analysis, isolates were
grouped on the basis of $98% similarity, in order to detect
dissemination of identical or near-identical strains.
Discriminatory ability of PCR/ESI-MS and rep-PCR
Strain types obtained by PCR/ESI-MS and rep-PCR patterns
were compared to establish concordance between the two typing
methods. The discriminatory abilities of PCR/ESI-MS and rep-
PCR were compared by contrasting the number of unique types
determined by each method, and by determining the Simpson’s
index of diversity (DI). This is an index of discrimination for
bacterial typing methods and was calculated using the following
formula [20,21]:
DI~1{
P S
i~1ni(ni{1)
N(N{1)
In the above equation, N is the total number of strains in the
sample population, S is the total number of types described, and ni
Figure 1. Origin, sequence type and antibiotic susceptibility of Acinetobacter baumannii from Ohio. Distribution of 122 A. baumannii
isolates by hospital of origin (hospitals A, B, C and D), year, sequence type (ST) determined by PCR/ESI-MS, worldwide clone type (WW) and
susceptibility to carbapenems and ampicillin/sulbactam.
doi:10.1371/journal.pone.0033443.g001
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th type. DI ranges from
0 to 1; a value closer to 1 represents larger diversity. 95%
confidence intervals were estimated for DI, according to previously
described equations [22]. DI and 95% confidence intervals were
calculated for PCR/ESI-MS, rep-PCR (analyzed with both the
KL and PC methods) and for the combination of PCR/ESI-MS
and rep-PCR.
Results
The 122 A. baumannii isolates included in this study were
represented by 17 different PCR/ESI-MS STs and by 29 and 27
different rep-PCR types, when analyzed with the KL and PC
methods, respectively. Overall, ST 10 (n=47), ST 14 (n=38) and
ST 12 (n=14), were the predominant ST types established by
PCR/ESI-MS (Table 1 and Figure 1).
Change of predominant sequence types over time
Our results indicate that different sequence types or separate
‘‘waves’’ of A. baumannii spread through different parts of Ohio in
past decades. Figures 1 and 2 illustrate the sequence and rep-PCR
types of A. baumannii from the four hospital systems in the three
different time periods analyzed. Among the 21 isolates from the
initial period of 1996, ST 14 was the predominant type (90% of
isolates). ST 14 corresponds to WW clone 3. Isolates from 2000
were characterized by the continued predominance of ST 14 (69%
of isolates). In the 2000 period however, 31% of isolates belonged
to ST 12, corresponding to WW clone 2. Among isolates from the
more recent period of 2007, ST 14 was not identified, while ST 12
represented only 8% of isolates. The predominant type in 2005–
2007 was ST 10 (63%), which also belongs to WW clone 2
(Figures 1 and 2 and Table 1). Susceptibility to carbapenems and
ampicillin/sulbactam was maintained in isolates from 1996 and
2000. More recent isolates, from 2005–2007, displayed increasing
resistance to these agents: non-susceptibility to carbapenems was
76.2% among A. baumannii isolates from 2007 (Figure 1).
There were many instances of almost identical rep-PCR types
(defined as $98% similar) present in different locations (data not
shown): hospital A shared isolates that were 99.2% similar
(belonging to ST 14) with hospital B, and a ST 1 isolate from
hospital A was 98% similar to ST 10 isolates from hospital D.
Strains belonging to ST 10 and ST 68 with $98% similarity were
found in hospitals C and D, while several ST 10/ST 12 isolates
from hospitals B and D were 98.1% similar.
Comparison and discriminatory power of PCR/ESI-MS
and rep-PCR
Isolates with the same STs belonged to multiple rep-PCR types
(Table 1). For example, the 38 isolates identified as ST 14 were
classified into five different rep-PCR types: two predominant
types, accounting for 74% and 18% of isolates respectively, and 3
unique types.
The Simpson’s index of diversity (DI) was determined to
compare the discriminatory ability of PCR/ESI-MS and rep-
PCR, analyzed by two different methods (KL and PC).
Additionally, DI was calculated for the combined analysis of
strain types with both PCR/ESI-MS and rep-PCR. Table 2 shows
different DI values for PCR/ESI-MS and rep-PCR, with
confidence intervals that do not overlap. The value of DI was
larger for the combination of PCR/ESI-MS and rep-PCR,
indicating a superior discriminatory power. There is, however,
overlap of the confidence interval with that of rep-PCR alone
indicating that differences in DI may not be significant. Note that
both methods of rep-PCR analysis (KL and PC) have a very
similar DI and confidence intervals, indicating essentially identical
discriminatory abilities.
Discussion
This decade-long study provided a unique view of the molecular
epidemiology of A. baumannii in two urban areas of a Midwestern
state in the USA. Of primary importance, we observed that there
was a change in the predominant sequence types of A. baumannii
associated with outbreaks from the four hospital systems, shifting
from carbapenem-susceptible strains corresponding to WW clone
3 in 1996, to carbapenem-resistant strains corresponding to WW
clone 2 in 2007. Secondly, we noted discordances in the type
assignments and differences in the discriminatory abilities of two
rapid automated typing methods. The higher discrimination of
rep-PCR makes it useful to chart hospital outbreaks, whereas the
PCR/ESI-MS delineates the underlying population structure.
Combining both methods may provide a more accurate
Table 1. Predominant PCR/ESI-MS sequence types and rep-PCR types analyzed by Kullback-Leibler (KL) and Pearson correlation
(PC) methods.
PCR/ESI-MS sequence type (ST) No. rep-PCR Kullback-Leibler (KL) type No. rep-PCR Pearson correlation (PC) type No.
ST 10* 47 KL 1 16 PC 1 10
ST 12* 14 KL 2 23 PC 2 20
ST 1* 3 KL 3 10 PC 3 5
ST 86* 1 KL 4 7 PC 4 21
KL 5 5 PC 5 5
Unique 4 PC 6 2
Unique 2
ST 14 38 KL 5 28 PC 7 28
KL 6 7 PC 8 7
Unique 3 Unique 3
ST 54 4 KL 7 2 PC 9 3
Unique 2 Unique 1
*rep-PCR did not differentiate among ST 10, ST 12, ST 1 and ST 86.
doi:10.1371/journal.pone.0033443.t001
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ogy studies comprising isolates of different years obtained from
several hospitals.
The isolates of A. baumannii analyzed in this study were restricted
to outbreak strains rather than those collected prospectively and
continuously. Nevertheless, we found, considerable diversity, 17 to
29 strain types, depending on the typing method used. Although
Figure 2. Genetic similarity among A. baumannii isolates. Representative A. baumannii isolates typed by rep-PCR, analyzed with the Kullback-
Leibler method. Five strain types with .95% similarity are illustrated, and further discriminated by year, hospital of origin, PCR-ESI/MS sequence type
(ST), and worldwide (WW) clone types.
doi:10.1371/journal.pone.0033443.g002
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three different time periods, we believe that our data provide early
clues as to the regional transmission dynamics of A. baumannii in
Ohio and perhaps even on a global level. The initial description of
European clones 1–3 dates from the mid-1990s and was inferred
from ribotyping, AFLP and PFGE typing of A. baumannii strains
associated with outbreaks throughout that continent
[15,23,24,25,26]. Presently, these clone types of A. baumannii
extend beyond Europe. For example, clonal clusters correspond-
ing to what is now termed worldwide (WW) clone 2 are widely
disseminated in multiple Chinese cities, and WW clone 2 has been
the predominant clonal type in a medical center in Australia for
more than a decade [27,28]. A contemporary international survey
of A. baumannii non-susceptible to carbapenems typed with rep-
PCR, PFGE and multiplex PCR, which led to change the
designation of European clones to WW clones, confirmed the
universal presence of clones 1–3, and identified clone 2 as the
largest and most widespread type [12]. Our analysis identified an
international strain of A. baumannii, WW clone 3, in the
Midwestern USA as early as 1996. This surprising result resonates
with ongoing questions as to the meaning and origin of these
successful global strains [29].
Previously, identification of WW clones 1–3 in the USA
occurred among A. baumannii obtained from patients at the Walter
Reed Army Medical Center in 2003–2005, and was subsequently
confirmed in isolates from 2006–2007 [6,19]. In these studies,
genetic typing with PCR/ESI-MS determined that WW clones 1–
3 were represented. Similarly, contemporary A. baumannii from the
National Naval Medical Center also included AFLP types
belonging to WW clones 1–3 [30]. This is in contrast with isolates
obtained in 2005–2007 and in 2008–2009 from civilian hospitals
across the United States (California, Arizona, Kentucky, Illlinois,
Pennsylvania, New York, Florida, Missouri and Nevada), where
WW clone 2 predominated and WW clones 1 and 3 were rarely
found [19,31]. Surveys of isolates recovered in 2001–2004 from 17
European countries revealed the co-dominance of WW clones 1
and 2, to the exclusion of WW clone 3 [32]. The emergence in
Italy and Greece of WW clone 2 among isolates obtained between
2005 and 2009 also supports this shift. [33,34]. Our data confirms
the replacement of WW clone 3 and the predominance of strains
related to WW clone 2 among A. baumannii causing outbreaks in
civilian hospitals in Ohio.
The determination of WW clones of A. baumannii has proven to
be consistent, even when diverse typing methods, such as rep-PCR
and PCR/ESI-MS, are used [12,17]. For instance, isolates
classified by PCR/ESI-MS as ST 1, ST 10, and ST 86 (all
belonging to WW clone 2) shared the same rep-PCR type. Of
note, the base composition of ST 1, ST 12, and ST 86 are single
locus variants of ST 10 in the PCR/ESI-MS scheme: they only
differ in one of the 6 housekeeping genes examined. Nevertheless,
disagreement in type assignment, for instance between PFGE and
PCR/ESI-MS or rep-PCR, can also occur [17]. In this study,
there was a trend towards a higher discriminatory ability using
both PCR/ESI-MS and rep-PCR, suggesting a significant benefit
in combining these two typing methods for A. baumannii. The value
of complementary typing methods has been previously recognized
for Aspergillus and Staphylococcus [14,35,36,37]. Our data also
demonstrate that the two different methods of analysis for rep-
PCR (KL and PC) result in very similar discriminatory abilities
(Table 2), but separate isolates into slightly different groupings
(Table 1). The presence of almost identical rep-PCR types in
different hospitals, even after increasing the threshold of similarity
from $95% to $98%, suggests potential clonal dissemination of
A. baumannii. This data must be interpreted carefully, however,
since we cannot provide other epidemiological evidence of patient-
to-patient spread occurring between hospitals.
The factors behind the widespread distribution of WW clones of
A. baumannii are not fully elucidated. Resistance to carbapenems
may in part explain the success of WW clone 2 in Ohio (and
globally), but we must keep in mind that the understanding of
antibiotic resistance and clonality in A. baumannii is evolving [38].
Commonly, up regulation of the intrinsic b-lactamase gene
blaOXA-51-like is considered the most prevalent mechanism of
carbapenem resistance among A. baumannii, whereas the blaOXA-23-
like gene is the predominant acquired mechanism of carbapenem
resistance, followed by the presence of blaOXA-58-like and blaOXA-24/
40-like genes [12]. Nevertheless, isolates belonging to WW clone 2
are frequently susceptible to carbapenems [25,27,28]. This is
underscored by our analysis, where WW clone 2 isolates from
2000 were susceptible to carbapenems. Furthermore, in the years
2005–2007, there was coexistence of WW clone 2 isolates resistant
and susceptible to carbapenems (Figure 1). Two previously
published, larger analyses of the carbapenem-resistant isolates
included in this study revealed blaOXA-23 and blaOXA-24/40 in
approximately 45% and 10% of strains from hospital D,
respectively [3]. In hospital C only 13% of isolates harbored
blaOXA-23, but 80% of isolates had ISAbaI linked to blaOXA-66,
a blaOXA-51-like gene [39].
In conclusion, an approach combining two different typing
methods increases our understanding of the molecular epidemi-
ology of A. baumannii in Ohio, revealing the regional predomi-
nance, temporal evolution, and progression of certain strain types.
Furthermore, our observations also help illustrate the potential
utility of combining rapid automated typing methods, such as
Table 2. Simpson’s Diversity index (DI) of PCR/ESI-MS, rep-PCR and the combination of PCR/ESI-MS and rep-PCR.
Typing method
Number of different
types
Percentage of isolates with the
most frequent type Simpson’s DI 95% Confidence interval
PCR/ESI-MS 17 39 0.744 0.692–0.796
rep-PCR
(Kullback-Leibler)
29 23 0.884 0.854–0.914
rep-PCR
(Pearson correlation)
27 23 0.882 0.852–0.912
PCR/ESI-MS+rep-PCR (Kullback-Leibler) 34 23 0.899 0.869–0.929
PCR/ESI-MS+rep-PCR
(Pearson correlation)
33 23 0.903 0.872–0.934
doi:10.1371/journal.pone.0033443.t002
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importantly, we also show that WW clone 3 was present in Ohio at
almost the same time as it was described in Europe. Our data also
demonstrates the replacement of WW clone 3 with WW clone 2 as
the predominant clone type, a pattern that is similar to national
and international trends. Despite limitations that challenge our
understanding of the transmission dynamics of A. baumannii, rapid
and automated molecular typing methods such as PCR/ESI-MS
and rep-PCR have demonstrated significant utility in evaluating
and documenting the dissemination of A. baumannii in various
geographic locations and time periods.
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